These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 31280930)
1. Transitional changes in the incidence of hip osteonecrosis among renal transplant recipients. Takao M; Abe H; Sakai T; Hamada H; Takahara S; Sugano N J Orthop Sci; 2020 May; 25(3):466-471. PubMed ID: 31280930 [TBL] [Abstract][Full Text] [Related]
2. Incidence and risk factors for osteonecrosis of the hip in renal transplant patients: a prospective single-centre study. Higuchi Y; Tomosugi T; Futamura K; Okada M; Narumi S; Watarai Y; Suzuki Y; Goto N; Ando T; Sato K Int Orthop; 2020 Oct; 44(10):1927-1933. PubMed ID: 32577876 [TBL] [Abstract][Full Text] [Related]
3. Symptomatic osteonecrosis of the femoral head after adult orthotopic liver transplantation. Li H; Zhang J; He JW; Wang K; Wang GS; Jiang N; Fu BS; Wang GY; Yang Y; Chen GH Chin Med J (Engl); 2012 Jul; 125(14):2422-6. PubMed ID: 22882914 [TBL] [Abstract][Full Text] [Related]
4. ApoB C7623T polymorphism predicts risk for steroid-induced osteonecrosis of the femoral head after renal transplantation. Hirata T; Fujioka M; Takahashi KA; Arai Y; Asano T; Ishida M; Kuribayashi M; Akioka K; Okamoto M; Yoshimura N; Satomi Y; Nishino H; Fukushima W; Hirota Y; Nakajima S; Kato S; Kubo T J Orthop Sci; 2007 May; 12(3):199-206. PubMed ID: 17530370 [TBL] [Abstract][Full Text] [Related]
5. Osteonecrosis of the femoral head in Japanese adults after liver transplantation: a preliminary report. Horiuchi H; Hashikura Y; Hisa K; Saito N; Ikegami T; Nakazawa Y; Karakida O; Kobayashi S; Nawata M; Kawasaki S; Takaoka K J Orthop Sci; 2004; 9(2):119-21. PubMed ID: 15045538 [TBL] [Abstract][Full Text] [Related]
6. [Analysis of incidence and clinical characteristics of osteonecrosis of femoral head in patients with systemic lupus erythematosus treated with glucocorticoid: A descriptive study based on a prospective cohort]. Xu Y; Chen S; Cai Q; Zhang C Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2023 May; 37(5):605-614. PubMed ID: 37190840 [TBL] [Abstract][Full Text] [Related]
7. Symptomatic osteonecrosis of the hip and knee after cardiac transplantation. Lieberman JR; Roth KM; Elsissy P; Dorey FJ; Kobashigawa JA J Arthroplasty; 2008 Jan; 23(1):90-6. PubMed ID: 18165036 [TBL] [Abstract][Full Text] [Related]
8. Early steroid withdrawal protocol with basiliximab, cyclosporine and mycophenolate mofetil in renal-transplant recipients. Kato Y; Tojimbara T; Iwadoh K; Koyama I; Nanmoku K; Kai K; Sannomiya A; Nakajima I; Fuchinoue S; Teraoka S Int Immunopharmacol; 2006 Dec; 6(13-14):1984-92. PubMed ID: 17161352 [TBL] [Abstract][Full Text] [Related]
9. Relationship between steroid dosage and osteonecrosis of the femoral head after renal transplantation as measured by magnetic resonance imaging. Kubo T; Fujioka M; Yamazoe S; Yoshimura N; Oka T; Ushijima Y; Hasegawa Y; Hirasawa Y Transplant Proc; 1998 Nov; 30(7):3039-40. PubMed ID: 9838339 [No Abstract] [Full Text] [Related]
10. Rabbit-ATG or basiliximab induction for rapid steroid withdrawal after renal transplantation (Harmony): an open-label, multicentre, randomised controlled trial. Thomusch O; Wiesener M; Opgenoorth M; Pascher A; Woitas RP; Witzke O; Jaenigen B; Rentsch M; Wolters H; Rath T; Cingöz T; Benck U; Banas B; Hugo C Lancet; 2016 Dec; 388(10063):3006-3016. PubMed ID: 27871759 [TBL] [Abstract][Full Text] [Related]
11. Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group. Nashan B; Moore R; Amlot P; Schmidt AG; Abeywickrama K; Soulillou JP Lancet; 1997 Oct; 350(9086):1193-8. PubMed ID: 9652559 [TBL] [Abstract][Full Text] [Related]
12. Comparative study of the cellular pharmacodynamics of tacrolimus in renal transplant recipients treated with and without basiliximab. Sugiyama K; Isogai K; Horisawa S; Toyama A; Satoh H; Saito K; Nakagawa Y; Tasaki M; Takahashi K; Hirano T Cell Transplant; 2012; 21(2-3):565-70. PubMed ID: 22793066 [TBL] [Abstract][Full Text] [Related]
13. Usefulness of Tacrolimus without Basiliximab in Well-Matched Living-Donor Renal Transplant Recipients in Korea. Baek CH; Kim JH; Yu H; Shin E; Cho H; Kim H; Yang WS; Han DJ; Park SK Exp Clin Transplant; 2016 Aug; 14(4):389-93. PubMed ID: 27228054 [TBL] [Abstract][Full Text] [Related]
14. [Total hip arthroplasty and femoral head osteonecrosis in renal transplant recipients]. Stromboni M; Menguy F; Hardy P; Leparc JM; Lortat-Jacob A; Benoit J Rev Chir Orthop Reparatrice Appar Mot; 2002 Sep; 88(5):467-74. PubMed ID: 12399711 [TBL] [Abstract][Full Text] [Related]
15. Basiliximab: a review of its use as induction therapy in renal transplantation. Chapman TM; Keating GM Drugs; 2003; 63(24):2803-35. PubMed ID: 14664658 [TBL] [Abstract][Full Text] [Related]
16. High triglyceride is a risk factor for silent osteonecrosis of the femoral head in systemic lupus erythematosus. Kuroda T; Tanabe N; Wakamatsu A; Takai C; Sato H; Nakatsue T; Wada Y; Nakano M; Narita I Clin Rheumatol; 2015 Dec; 34(12):2071-7. PubMed ID: 26384821 [TBL] [Abstract][Full Text] [Related]
17. Cardiovascular and Cerebrovascular Events Are Associated With Nontraumatic Osteonecrosis of the Femoral Head. Sung PH; Yang YH; Chiang HJ; Chiang JY; Chen CJ; Yip HK; Lee MS Clin Orthop Relat Res; 2018 Apr; 476(4):865-874. PubMed ID: 29480889 [TBL] [Abstract][Full Text] [Related]
18. Incidence and Risk Factors of Osteonecrosis of Femoral Head in Multiple Myeloma Patients Undergoing Dexamethasone-Based Regimens. Wu X; Geng C; Sun W; Tan M Biomed Res Int; 2020; 2020():7126982. PubMed ID: 32509867 [TBL] [Abstract][Full Text] [Related]
19. The influence of age, gender and treatment with steroids on the incidence of osteonecrosis of the femoral head during the management of severe acute respiratory syndrome: a retrospective study. Guo KJ; Zhao FC; Guo Y; Li FL; Zhu L; Zheng W Bone Joint J; 2014 Feb; 96-B(2):259-62. PubMed ID: 24493194 [TBL] [Abstract][Full Text] [Related]
20. Degree of corticosteroid treatment within the first 2 months of renal transplantation has a strong influence on the incidence of osteonecrosis of the femoral head. Shibatani M; Fujioka M; Arai Y; Takahashi K; Ueshima K; Okamoto M; Yoshimura N; Hirota Y; Fukushima W; Kubo T Acta Orthop; 2008 Oct; 79(5):631-6. PubMed ID: 18839369 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]